| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.81B | 71.52B | 72.63B | 63.53B | 59.54B | 51.54B |
| Gross Profit | 25.45B | 26.36B | 25.25B | 22.46B | 20.36B | 19.05B |
| EBITDA | 5.62B | 5.79B | 6.22B | 5.44B | 4.45B | 4.66B |
| Net Income | 2.04B | 1.48B | 2.17B | 2.01B | 1.68B | 1.84B |
Balance Sheet | ||||||
| Total Assets | 36.54B | 41.83B | 42.25B | 40.92B | 36.15B | 32.77B |
| Cash, Cash Equivalents and Short-Term Investments | 9.69B | 12.43B | 11.41B | 11.93B | 11.16B | 10.17B |
| Total Debt | 2.10B | 2.35B | 2.73B | 4.54B | 2.50B | 2.63B |
| Total Liabilities | 17.61B | 20.44B | 22.54B | 23.17B | 20.52B | 18.40B |
| Stockholders Equity | 16.75B | 18.91B | 17.54B | 16.50B | 14.65B | 13.45B |
Cash Flow | ||||||
| Free Cash Flow | 3.51B | 2.77B | 3.93B | 2.24B | 2.47B | 1.72B |
| Operating Cash Flow | 3.68B | 3.07B | 4.14B | 3.17B | 3.28B | 2.59B |
| Investing Cash Flow | -1.28B | -769.36M | -1.36B | -1.06B | -912.71M | -912.68M |
| Financing Cash Flow | -2.56B | -1.53B | -3.31B | -1.45B | -1.39B | -2.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥29.62B | 10.77 | ― | 4.36% | 7.11% | 20.03% | |
79 Outperform | ¥25.54B | 16.28 | ― | 2.18% | 10.92% | 31.97% | |
75 Outperform | ¥25.54B | 10.52 | ― | 1.21% | 5.85% | 5.71% | |
75 Outperform | ¥21.93B | 11.46 | ― | 3.93% | 9.72% | 1.57% | |
70 Outperform | ¥25.05B | 50.86 | ― | ― | 31.09% | 75.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥27.10B | 19.53 | ― | 2.51% | -1.52% | -31.82% |